vs
艾伯维(ABBV)与富国银行(WFC)财务数据对比。点击上方公司名可切换其他公司
富国银行的季度营收约是艾伯维的1.3倍($21.3B vs $16.6B),富国银行净利率更高(25.2% vs 10.9%,领先14.3%),艾伯维同比增速更快(10.0% vs 4.5%),过去两年艾伯维的营收复合增速更高(16.2% vs 1.0%)
艾伯维是一家总部位于美国伊利诺伊州北芝加哥的制药企业,专注于研发、生产覆盖多种疾病领域的治疗药物,致力于为全球各地患者提供安全有效的临床解决方案,在全球医药行业拥有较高的知名度与影响力。
富国银行是美国头部跨国金融服务机构,位列美国四大银行之一,业务覆盖全球35个国家,为超7000万全球客户提供服务,被金融稳定委员会认定为系统重要性金融机构,具备较高的行业影响力。
ABBV vs WFC — 直观对比
营收规模更大
WFC
是对方的1.3倍
$16.6B
营收增速更快
ABBV
高出5.6%
4.5%
净利率更高
WFC
高出14.3%
10.9%
两年增速更快
ABBV
近两年复合增速
1.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $16.6B | $21.3B |
| 净利润 | $1.8B | $5.4B |
| 毛利率 | 72.6% | — |
| 营业利润率 | 27.3% | 30.7% |
| 净利率 | 10.9% | 25.2% |
| 营收同比 | 10.0% | 4.5% |
| 净利润同比 | 8354.5% | 5.6% |
| 每股收益(稀释后) | $1.02 | $1.61 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ABBV
WFC
| Q4 25 | $16.6B | $21.3B | ||
| Q3 25 | $15.8B | $21.4B | ||
| Q2 25 | $15.4B | $20.8B | ||
| Q1 25 | $13.3B | $20.1B | ||
| Q4 24 | $15.1B | $20.4B | ||
| Q3 24 | $14.5B | $20.4B | ||
| Q2 24 | $14.5B | $20.7B | ||
| Q1 24 | $12.3B | $20.9B |
净利润
ABBV
WFC
| Q4 25 | $1.8B | $5.4B | ||
| Q3 25 | $186.0M | $5.6B | ||
| Q2 25 | $938.0M | $5.5B | ||
| Q1 25 | $1.3B | $4.9B | ||
| Q4 24 | $-22.0M | $5.1B | ||
| Q3 24 | $1.6B | $5.1B | ||
| Q2 24 | $1.4B | $4.9B | ||
| Q1 24 | $1.4B | $4.6B |
毛利率
ABBV
WFC
| Q4 25 | 72.6% | — | ||
| Q3 25 | 66.4% | — | ||
| Q2 25 | 71.8% | — | ||
| Q1 25 | 70.0% | — | ||
| Q4 24 | 70.9% | — | ||
| Q3 24 | 70.9% | — | ||
| Q2 24 | 70.9% | — | ||
| Q1 24 | 66.7% | — |
营业利润率
ABBV
WFC
| Q4 25 | 27.3% | 30.7% | ||
| Q3 25 | 12.1% | 32.2% | ||
| Q2 25 | 31.7% | 30.9% | ||
| Q1 25 | 28.0% | 26.4% | ||
| Q4 24 | -9.9% | 26.4% | ||
| Q3 24 | 26.5% | 30.6% | ||
| Q2 24 | 27.6% | 29.8% | ||
| Q1 24 | 22.7% | 26.8% |
净利率
ABBV
WFC
| Q4 25 | 10.9% | 25.2% | ||
| Q3 25 | 1.2% | 26.1% | ||
| Q2 25 | 6.1% | 26.4% | ||
| Q1 25 | 9.6% | 24.3% | ||
| Q4 24 | -0.1% | 24.9% | ||
| Q3 24 | 10.8% | 25.1% | ||
| Q2 24 | 9.5% | 23.7% | ||
| Q1 24 | 11.1% | 22.1% |
每股收益(稀释后)
ABBV
WFC
| Q4 25 | $1.02 | $1.61 | ||
| Q3 25 | $0.10 | $1.66 | ||
| Q2 25 | $0.52 | $1.60 | ||
| Q1 25 | $0.72 | $1.39 | ||
| Q4 24 | $-0.03 | $1.42 | ||
| Q3 24 | $0.88 | $1.42 | ||
| Q2 24 | $0.77 | $1.33 | ||
| Q1 24 | $0.77 | $1.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $5.3B | — |
| 总债务越低越好 | $58.9B | $174.7B |
| 股东权益账面价值 | $-3.3B | $181.1B |
| 总资产 | $134.0B | $2148.6B |
| 负债/权益比越低杠杆越低 | — | 0.96× |
8季度趋势,按日历期对齐
现金及短期投资
ABBV
WFC
| Q4 25 | $5.3B | — | ||
| Q3 25 | $5.7B | — | ||
| Q2 25 | $6.5B | — | ||
| Q1 25 | $5.2B | — | ||
| Q4 24 | $5.6B | — | ||
| Q3 24 | $7.3B | — | ||
| Q2 24 | $13.2B | — | ||
| Q1 24 | $18.1B | — |
总债务
ABBV
WFC
| Q4 25 | $58.9B | $174.7B | ||
| Q3 25 | $63.0B | $177.8B | ||
| Q2 25 | $63.0B | $176.2B | ||
| Q1 25 | $64.5B | $173.7B | ||
| Q4 24 | $60.3B | $173.1B | ||
| Q3 24 | $58.5B | $182.0B | ||
| Q2 24 | $58.0B | $179.1B | ||
| Q1 24 | $63.8B | $187.8B |
股东权益
ABBV
WFC
| Q4 25 | $-3.3B | $181.1B | ||
| Q3 25 | $-2.6B | $181.2B | ||
| Q2 25 | $-183.0M | $181.1B | ||
| Q1 25 | $1.4B | $181.1B | ||
| Q4 24 | $3.3B | $179.1B | ||
| Q3 24 | $6.0B | $183.3B | ||
| Q2 24 | $6.8B | $176.4B | ||
| Q1 24 | $8.0B | $180.9B |
总资产
ABBV
WFC
| Q4 25 | $134.0B | $2148.6B | ||
| Q3 25 | $133.9B | $2062.9B | ||
| Q2 25 | $137.2B | $1981.3B | ||
| Q1 25 | $136.2B | $1950.3B | ||
| Q4 24 | $135.2B | $1929.8B | ||
| Q3 24 | $143.4B | $1922.1B | ||
| Q2 24 | $141.9B | $1940.1B | ||
| Q1 24 | $148.9B | $1959.2B |
负债/权益比
ABBV
WFC
| Q4 25 | — | 0.96× | ||
| Q3 25 | — | 0.98× | ||
| Q2 25 | — | 0.97× | ||
| Q1 25 | 45.44× | 0.96× | ||
| Q4 24 | 18.15× | 0.97× | ||
| Q3 24 | 9.70× | 0.99× | ||
| Q2 24 | 8.56× | 1.02× | ||
| Q1 24 | 7.97× | 1.04× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $5.2B | $4.1B |
| 自由现金流经营现金流 - 资本支出 | $4.9B | — |
| 自由现金流率自由现金流/营收 | 29.4% | — |
| 资本支出强度资本支出/营收 | 2.0% | — |
| 现金转化率经营现金流/净利润 | 2.87× | 0.77× |
| 过去12个月自由现金流最近4个季度 | $17.8B | — |
8季度趋势,按日历期对齐
经营现金流
ABBV
WFC
| Q4 25 | $5.2B | $4.1B | ||
| Q3 25 | $7.0B | $-869.0M | ||
| Q2 25 | $5.2B | $-11.2B | ||
| Q1 25 | $1.6B | $-11.0B | ||
| Q4 24 | $7.0B | $8.9B | ||
| Q3 24 | $5.4B | $4.2B | ||
| Q2 24 | $2.3B | $2.0B | ||
| Q1 24 | $4.0B | $-12.1B |
自由现金流
ABBV
WFC
| Q4 25 | $4.9B | — | ||
| Q3 25 | $6.6B | — | ||
| Q2 25 | $4.9B | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $6.8B | — | ||
| Q3 24 | $5.2B | — | ||
| Q2 24 | $2.0B | — | ||
| Q1 24 | $3.8B | — |
自由现金流率
ABBV
WFC
| Q4 25 | 29.4% | — | ||
| Q3 25 | 42.1% | — | ||
| Q2 25 | 31.7% | — | ||
| Q1 25 | 10.5% | — | ||
| Q4 24 | 44.7% | — | ||
| Q3 24 | 35.9% | — | ||
| Q2 24 | 14.0% | — | ||
| Q1 24 | 31.3% | — |
资本支出强度
ABBV
WFC
| Q4 25 | 2.0% | — | ||
| Q3 25 | 2.4% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 1.8% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 1.6% | — |
现金转化率
ABBV
WFC
| Q4 25 | 2.87× | 0.77× | ||
| Q3 25 | 37.76× | -0.16× | ||
| Q2 25 | 5.49× | -2.04× | ||
| Q1 25 | 1.27× | -2.26× | ||
| Q4 24 | — | 1.75× | ||
| Q3 24 | 3.49× | 0.82× | ||
| Q2 24 | 1.66× | 0.42× | ||
| Q1 24 | 2.95× | -2.63× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABBV
暂无分部数据
WFC
| Other | $5.2B | 24% |
| Wealth And Investment Management | $3.4B | 16% |
| Investment Advisory Management And Administrative Service | $2.8B | 13% |
| Corporate And Investment Banking | $2.5B | 12% |
| Consumer Banking And Lending | $2.0B | 10% |
| Commercial Portfolio Segment | $1.1B | 5% |
| Commercial Banking | $1.1B | 5% |
| Credit Card Rewards And Rebates | $859.0M | 4% |
| Investment Advice | $716.0M | 3% |
| Deposit Account | $692.0M | 3% |
| Commissions And Brokerage Service Fees | $657.0M | 3% |
| Trailing Commission | $250.0M | 1% |